Human T-cell Leukemia Virus Type 1 - 25 Studies Found
Recruiting |
: Evaluation of Patients With HAM/TSP :
: 1999-11-03 |
Completed |
: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV I Associated Myelopathy : 2008-10-15 : Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Completed |
: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis : HTLV-I : 2006-06-19 |
Completed |
: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) : HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) : 2011-08-16 : Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases :
|
Terminated |
: The HAM Infliximab Study : HTLV-I-associated Myelopathy : 2009-01-14 : Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Recruiting |
: Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus : HTLV-1 : 2016-08-11 : Other: Video game The protocol sensorimotor exercises consist of a virtual game that attaches to the Nin |
Enrolling by invitation |
: Evaluation of InnoLIA HTLV I/II Score : Human T-Lymphotrophic Virus Type I and/or Type II : 2010-06-22 : Device: InnoLIA HTLV I/II Score line immunoassay This intervention consists of testing a residual serum |
Terminated |
: Safety and Efficiency Study of Valproic Acid In HAM/TSP : HTLV-I-Associated Myelopathy : 2007-08-20 : Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Completed |
: Anti-Tac for Treatment of Leukemia :
: 2000-01-18 : Biological: daclizumab Other Name: Zenapax |